PRL and hyperprolactinemia: Similarly, Tirosh et al. reported in a single-center, historical prospective study of 71 men with pituitary macroadenomas and hyperprolactinemia that a decrease in serum PRL after 6 months of DA therapy was a strong predictor of long-term PRL normalization.